Dan Roden

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records. Read More

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given. Read More

A new faculty task force has been appointed to prioritize and refine the eight health-related initiatives in the Academic Strategic Plan and to inventory existing health-related interdisciplinary centers and institutes at Vanderbilt. Read More

The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors. Read More

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH). Read More

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection. Read More

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week. Read More

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

L-r: Raymond DuBois, Jeff Balser and Dan Roden. (Steve Green/Vanderbilt) “Personalized medicine—the effort to tailor health care to understand individual patients’ needs, genetic profiles and circumstances—is a big emphasis at the Vanderbilt University Medical Center,” said Jeff Balser, vice chancellor for health affairs and dean of… Read More

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles. Read More

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research. Read More

Watch video of the Chancellor’s Lecture Series, featuring a talk by Dr. Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine” Roden is widely-recognized for his expertise in clinical, genetic, cellular, and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies. Over the past decade, he… Read More

The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University. Read More

This month BioVU logged in its 150,000th unique genetic sample. It is now the world’s largest collection of human DNA linked to searchable, electronic health information. Read More

The director of Vanderbilt’s DNA databank will discuss the possibilities of personalized medicine in the first Chancellor’s Lecture of the academic year. Read More

Females may be at higher risk of potentially fatal heart condition due to gender differences in a protein involved in the heart’s electrical activity. Read More

Jim Jirjis (Vanderbilt) The March edition of My Health Chat will focus on the broad implications for the future of medicine presented by the sequencing of the human genome. Host Jim Jirjis will be joined March 7 by Gordon Bernard, Vanderbilt University Medical Center’s associate vice chancellor… Read More

Vanderbilt researchers are seeking genetic clues to explain why risk factors for AF are more prevalent in African-Americans but their incidence of the disease is lower than European-Americans. Read More

Watch video of Dr. Dan Roden speaking about personalized medicine. Roden spoke Jan. 25 as part of the Osher Lifelong Learning class, “Medical Advances.” The course is presented by faculty of the Vanderbilt University Medical Center and focuses on what the future of medicine holds. Physicians are now able to use… Read More

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy. Read More